4.7 Article

CXCR4-targeted nanotoxins induce GSDME-dependent pyroptosis in head and neck squamous cell carcinoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pharmacology & Pharmacy

Self-assembling protein nanocarrier for selective delivery of cytotoxic polypeptides to CXCR4+ head and neck squamous cell carcinoma tumors

Elisa Rioja-Blanco et al.

Summary: This study validates the potential use of T22-GFP-H6 as a nanocarrier to selectively deliver drugs to CXCR4(+) tumors in HNSCC, showing promising therapeutic effects without causing histological alterations in normal organs.

ACTA PHARMACEUTICA SINICA B (2022)

Review Chemistry, Multidisciplinary

Cell Death Mediated by the Pyroptosis Pathway with the Aid of Nanotechnology: Prospects for Cancer Therapy

Dan Wu et al.

Summary: Pyroptosis, a unique form of programmed cell death, has been closely associated with human diseases like inflammatory diseases and malignant tumors. Recent progress in cancer treatment based on nanoparticles-induced pyroptosis highlights design features and therapeutic advantages, while also proposing future directions in this emerging area.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)

Review Biochemistry & Molecular Biology

Switching from Apoptosis to Pyroptosis: Gasdermin-Elicited Inflammation and Antitumor Immunity

Kohsuke Tsuchiya

Summary: Pyroptosis is a regulated form of cell death, executed by Gasdermines (GSDMs) that form pores in the plasma membrane leading to cell lysis. Pyroptotic cells release pro-inflammatory molecules, eliciting inflammation and immune responses. Recent studies have advanced our understanding of pyroptosis mechanisms and roles, which may aid in the development of cancer immunotherapy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Peripheral Vascular Disease

High NOR-1 (Neuron-Derived Orphan Receptor 1) Expression Strengthens the Vascular Wall Response to Angiotensin II Leading to Aneurysm Formation in Mice

Laia Canes et al.

Summary: Drug therapy for limiting abdominal aortic aneurysm growth or rupture is currently ineffective, and there is incomplete understanding of disease biology. The nuclear receptor NOR-1 plays a role in AAA by amplifying the vascular response to Ang II, leading to vascular inflammation, MMP activity increase, and elastin integrity disturbance. Overexpression of NOR-1 in vascular smooth muscle cells in mice models strengthens the response to Ang II, contributing to the formation of AAA.

HYPERTENSION (2021)

Review Cell Biology

Cell death in head and neck cancer pathogenesis and treatment

Martina Raudenska et al.

Summary: Many cancer therapies target apoptosis in cancer cells, but the presence of oncogenic alterations and tumor microenvironment composition limit their efficacy. There are about 10 different cell death subroutines that cancer cells cannot avoid, highlighting the need for individualized therapy. Understanding the molecular heterogeneity of tumors and their cell death pathways is crucial for improving treatment response.

CELL DEATH & DISEASE (2021)

Review Oncology

Induction of Pyroptosis: A Promising Strategy for Cancer Treatment

Lei Wang et al.

Summary: Pyroptosis is a lytic pro-inflammatory type of programmed cell death that has a complex relationship with cancer. It can provide a comfortable environment for tumor proliferation as inflammatory cell death, but excessive activation can also inhibit the development of tumor cells.

FRONTIERS IN ONCOLOGY (2021)

Review Oncology

Molecular Mechanisms of Chemotherapy Resistance in Head and Neck Cancers

Yuzuka Kanno et al.

Summary: This review discusses the molecular mechanisms of chemotherapy resistance in head and neck cancer and potential strategies for improving treatment outcomes, suggesting combination therapies with immunotherapy may be beneficial for prolonging survival.

FRONTIERS IN ONCOLOGY (2021)

Review Immunology

Recent development and optimization of pseudomonas aeruginosa exotoxin immunotoxins in cancer therapeutic applications

Tong Wu et al.

Summary: Recombinant immunotoxins are fusion proteins designed through genetic recombination, consisting of a peptide toxin and a targeting domain to recognize disease-specific receptors and induce cell death. Efforts are ongoing to address challenges such as immunogenicity and non-specific cytotoxicity, with recent strategies for structural optimization and mutagenesis showing promise in enhancing safety and efficacy. These immunotoxins are expected to play a crucial role in cancer therapy, with continuous advancements in design concepts and development prospects.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Review Oncology

Therapeutic Potential of Antibody-Drug Conjugate-Based Therapy in Head and Neck Cancer: A Systematic Review

Vittoria Perrotti et al.

Summary: Despite advancements in understanding molecular mechanisms and developing new therapies for head and neck cancer, the disease remains challenging, with a relatively low 5-year survival rate and limited representation in clinical trials. Targeted therapies tailored for the HNC phenotype may offer new treatment perspectives.

CANCERS (2021)

Review Biochemistry & Molecular Biology

Pyroptosis: mechanisms and diseases

Pian Yu et al.

Summary: Pyroptosis has gained attention for its association with innate immunity and diseases. The discovery of the gasdermin family has expanded the research scope of pyroptosis, revealing its potential effects on tumor development. Pyroptosis serves as a double-edged sword in tumors, with the rational utilization of its dual effect providing insights for new drug development and understanding tumor formation and progression.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Review Chemistry, Medicinal

Critical Issues in the Development of Immunotoxins for Anticancer Therapy

Ji-Sun Kim et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2020)

Article Multidisciplinary Sciences

Gasdermin E suppresses tumour growth by activating anti-tumour immunity

Zhibin Zhang et al.

NATURE (2020)

Article Pharmacology & Pharmacy

Miltirone induces cell death in hepatocellular carcinoma cell through GSDME-dependent pyroptosis

Xiaowei Zhang et al.

ACTA PHARMACEUTICA SINICA B (2020)

Article Multidisciplinary Sciences

Combinatorial entropy behaviour leads to range selective binding in ligand-receptor interactions

Meng Liu et al.

NATURE COMMUNICATIONS (2020)

Article Medicine, General & Internal

Head and neck squamous cell carcinoma

Daniel E. Johnson et al.

NATURE REVIEWS DISEASE PRIMERS (2020)

Review Oncology

The changing therapeutic landscape of head and neck cancer

John D. Cramer et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2019)

Review Cell Biology

The role of pyroptosis in cancer: pro-cancer or pro-host?

Xiaojing Xia et al.

CELL DEATH & DISEASE (2019)

Review Oncology

Induction of Pyroptosis and Its Implications in Cancer Management

Yan-Yang Wang et al.

FRONTIERS IN ONCOLOGY (2019)

Review Public, Environmental & Occupational Health

Safety and Tolerability of Antibody-Drug Conjugates in Cancer

Anna Wolska-Washer et al.

DRUG SAFETY (2019)

Review Oncology

Clinical toxicity of antibody drug conjugates: a meta-analysis of payloads

Joanna C. Masters et al.

INVESTIGATIONAL NEW DRUGS (2018)

Article Chemistry, Multidisciplinary

Self-assembling toxin-based nanoparticles as self-delivered antitumoral drugs

Laura Sanchez-Garcia et al.

JOURNAL OF CONTROLLED RELEASE (2018)

Review Biochemistry & Molecular Biology

Immunotoxins Targeting B cell Malignancy-Progress and Problems With Immunogenicity

Daniel A. Vallera et al.

BIOMEDICINES (2018)

Article Multidisciplinary Sciences

Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin

Yupeng Wang et al.

NATURE (2017)

Review Biotechnology & Applied Microbiology

Strategies and challenges for the next generation of antibody drug conjugates

Alain Beck et al.

NATURE REVIEWS DRUG DISCOVERY (2017)

Article Otorhinolaryngology

Expression of the CXCL12/CXCR4 chemokine axis predicts regional control in head and neck squamous cell carcinoma

Xavier Leon et al.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2016)

Review Oncology

Current Treatment Options for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Assuntina G. Sacco et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

Article Oncology

Advances in Anticancer Immunotoxin Therapy

Christine Alewine et al.

ONCOLOGIST (2015)

Article Chemistry, Multidisciplinary

In Vivo Architectonic Stability of Fully de Novo Designed Protein-Only Nanoparticles

Maria Virtudes Cespedes et al.

ACS NANO (2014)

Review Oncology

Cancer drug resistance: an evolving paradigm

Caitriona Holohan et al.

NATURE REVIEWS CANCER (2013)

Article Biochemistry & Molecular Biology

Methylation of the DFNA5 increases risk of lymph node metastasis in human breast cancer

Myoung Sook Kim et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)

Review Oncology

Mesothelin targeted cancer immunotherapy

Raffit Hassan et al.

EUROPEAN JOURNAL OF CANCER (2008)

Article Oncology

Immunotoxin therapy of cancer

Ira Pastan et al.

NATURE REVIEWS CANCER (2006)

Article Biochemistry & Molecular Biology

DFNA5 (ICERE-1) contributes to acquired etoposide resistance in melanoma cells

H Lage et al.

FEBS LETTERS (2001)